| 000 | 01669cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030311.0 | ||
| 008 | 101024s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.33.Ph.D.2010.Kh.S | ||
| 100 | 0 | _aKhalid Hassan Elsherif | |
| 245 | 1 | 0 |
_aSafety and efficcacy of plasmid mediated thromboietin gene therapy in the treatment of thrombocytopenia secondary to chronic liver disease / _cKhalid Hassan Elsherif ; Supervised Laila Ahmed , Hosny Salama , Wafaa Elmetenawy |
| 246 | 1 | 5 | _aعلاج نقص الصفائح الدموية الناتج عن أمراض الكبد المزمنة عن طريق حقن جين الثرومبوبويتين |
| 260 |
_aCairo : _bKhalid Hassan Elsherif , _c2010 |
||
| 300 |
_a149P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine | ||
| 520 | _aThrombocytopenia is a common complication in patients with chronic liver disease it occurs in about 76% in cirrhotic patients . Thrombocytopenia secondary to chronic liver disease is mainly due to ; Thrombopoiein deficiency , hypersplenism, bone marrow suppression and autoimmune mechanism | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHypersplenism | |
| 653 | 4 | _aThrombopoiein | |
| 653 | 4 | _aTPO gene therapy | |
| 700 | 0 |
_aHosny Salama , _eSupervisor |
|
| 700 | 0 |
_aLaila Ahmed , _eSupervisor |
|
| 700 | 0 |
_aWafaa Elmetenawy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c31842 _d31842 |
||